NEW YORK ( TheStreet) -- Antares Pharma (Nasdaq: ATRS) hit a new 52-week high Tuesday as it is currently trading at $3.84, above its previous 52-week high of $3.75 with 325,626 shares traded as of 9:40 a.m. ET. Average volume has been one million shares over the past 30 days. Antares has a market cap of $369.1 million and is part of the health care sector and health services industry. Shares are up 60.9% year to date as of the close of trading on Monday. Antares Pharma Inc., a pharmaceutical company, engages in the development and marketing of self-injection pharmaceutical products and technologies, and topical gel-based products.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!